- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: maximum tolerable dose
Total 21233 results
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedPostmenopauseUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, MajorUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedRheumatoid ArthritisJapan
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDiabetes MellitusJapan
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedOsteoarthritis | Healthy SubjectsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDiabetes MellitusUnited States
-
NovartisCompleted
-
University of WashingtonSanofiCompletedProstate CancerUnited States
-
Mount Sinai Hospital, CanadaPfizer; Canadian Institutes of Health Research (CIHR)TerminatedRecurrent Pregnancy Loss | Antiphospholipid Antibody SyndromeCanada
-
Eli Lilly and CompanyCompleted
-
Geriatric Oncology ConsortiumSanofiCompletedProstate CancerUnited States
-
Grünenthal GmbHTerminated
-
Grünenthal GmbHTerminated
-
Geriatric Oncology ConsortiumSanofiTerminatedBreast Cancer | Lung CancerUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Mackay Memorial HospitalCompleted
-
Deutsches Herzzentrum MuenchenTechnical University of MunichCompleted
-
GP-PharmCompletedProstate CancerUnited States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
-
James A. Haley Veterans Administration HospitalHoffmann-La RocheTerminated
-
Institut de Recherches Cliniques de MontrealTerminatedHypertension | Type 2 Diabetes | AlbuminuriaCanada
-
NovaceaSchering-PloughSuspended
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
Karolinska University HospitalMuhimbili University of Health and Allied SciencesCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderCanada, United States
-
Assaf-Harofeh Medical CenterUnknown
-
Eli Lilly and CompanyICOS CorporationCompletedErectile DysfunctionUnited States
-
Chap, Linnea I., M.D.Genentech, Inc.UnknownBreast CancerUnited States
-
Eli Lilly and CompanyICOS CorporationCompleted
-
University of WuerzburgUnknownMultiple MyelomaGermany, Austria
-
HiberCell, Inc.Completed
-
HiberCell, Inc.Completed
-
Herlev HospitalEli Lilly and Company; SanofiCompleted
-
Bristol-Myers SquibbCompletedHIV Infections | Anorexia | CachexiaUnited States
-
Tuen Mun HospitalCompleted
-
Bayside HealthThe AlfredUnknownKidney Failure, Chronic | Heart Failure, CongestiveAustralia
-
NeurogesXUnknownHIV InfectionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
NITROX, LLCWithdrawnPulmonary HypertensionUnited States
-
Medicines for Malaria VentureRanbaxy Laboratories Limited; Swiss Tropical & Public Health InstituteCompletedPlasmodium Falciparum MalariaIndia, Tanzania, Thailand
-
Nathan Kline Institute for Psychiatric ResearchStanley Medical Research InstituteCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieNo longer available
-
University of BolognaNovartisCompletedChronic Myeloid LeukemiaItaly
-
Norwegian Institute of Public HealthCompletedImmunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccinePertussis | Tetanus | Diphtheria | PolioNorway
-
Profil Institut für Stoffwechselforschung GmbHNovo Nordisk A/SCompleted
-
University Hospital, MontpellierCompleted
-
GSVM Medical CollegeCompletedTuberculosis, Multidrug-Resistant